Biodexa Pharmaceuticals (BDRX)
NASDAQ: BDRX
· Real-Time Price · USD
0.85
-0.19 (-18.27%)
At close: Jun 17, 2025, 2:07 PM
-18.27% (1D)
| Bid | 0.84 |
| Market Cap | 696 |
| Revenue (ttm) | 83K |
| Net Income (ttm) | -6.82M |
| EPS (ttm) | -13.56 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.85 |
| Volume | 1,126,845 |
| Avg. Volume (20D) | 2,198,474 |
| Open | 1.03 |
| Previous Close | 1.04 |
| Day's Range | 0.78 - 1.05 |
| 52-Week Range | 0.79 - 41.50 |
| Beta | 1.21 |
About BDRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BDRX
Website n/a
3 weeks ago
+6.92%
Biodexa Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
1 month ago
-12.77%
BDRX stock has given up its prior gain. Biodexa Pharmaceuticals shares were trading higher after the company received orphan drug designation in Europe for eRapa in treating familial adenomatous polyposis.
